WR
William G. Rice
Chair, President & CEO

William G. Rice insider trades: Aptose Biosciences (APTO) stock buys and sales

Chair, President & CEO, Aptose Biosciences Last trade Nov 25, 2024 21 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
12
Open-market trades
since 2019
1
Company
last trade 2024

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where William reports to the SEC

Open-market buys and sales

12 trades reported on SEC Form 4, newest first

DateStockTypeValue
Nov 25, 2024APTO↑ Buy$20K
Sep 19, 2022APTO↑ Buy$7K
Jun 6, 2022APTO↑ Buy$10K
Dec 16, 2021APTO↑ Buy$20K
Dec 15, 2021APTO↑ Buy$20K
Nov 26, 2021APTO↑ Buy$20K
Jul 2, 2021APTO↑ Buy$20K
Jul 10, 2020APTO↓ Sell$1.0M
Mar 25, 2020APTO↑ Buy$20K
Oct 24, 2019APTO↑ Buy$19K
Apr 18, 2019APTO↑ Buy$19K
Mar 14, 2019APTO↑ Buy$19K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About William G. Rice's insider trades

William G. Rice is Chair, President & CEO at Aptose Biosciences (APTO). Since Mar 14, 2019, William has reported 11 open-market purchases worth $193K and 1 sale worth $1.0M on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (8 filings), shares returned to the company (1 filing), other transactions (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every APTO insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.